Stevanato Group logo — Managing complexity, delivering value.

Stevanato Group

Managing complexity, delivering value.

Founded 1949 Italy Italy 2414 employees Post-IPO Equity Total: $555.00M Health Care, Manufacturing +1

General Information

Company Name Stevanato Group
Founded Year 1949
Location Italy Italy
Employees 2414
Industries Health Care, Manufacturing, Pharmaceutical
Funding Stage Post-IPO Equity
Social

BounceWatch is an independent company data service, not affiliated with Stevanato Group. To contact Stevanato Group, visit stevanatogroup.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Stevanato Group compare?

A PDF of Stevanato Group and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Stevanato Group soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Stevanato Group

Stevanato Group, founded in 1949, is a global leader in integrated containment and delivery solutions for the biopharmaceutical industry. The company's expertise lies in its proprietary glass forming technology, ensuring the highest quality standards for its products. With a diverse portfolio, including glass containers under the Ompi brand, plastic components for diagnostics and medical devices, contract manufacturing services for drug delivery systems, and inspection, assembly, and packaging machines, Stevanato Group caters to the entire biopharmaceutical and diagnostic industry. An important differentiator for the group is its provision of analytical services and tests that focus on the interaction between the container and drug, aiding integration into delivery systems and supporting the drug development process. By consolidating these diverse capabilities, Stevanato Group uniquely offers solutions that reduce both time to market and overall costs for companies in the biopharmaceutical sector. Notably, the company's most recent milestone includes a significant $330.00M Post-IPO Equity investment at 21 March 2024, signifying confidence in its growth trajectory. Headquartered in Italy, Stevanato Group continues to demonstrate its integral role in shaping the future of the biopharmaceutical industry.

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Equity $330.00M -
21 Mar 2024
Post IPO Debt €130.00M 2
CDP VC, BNL BNP Paribas
08 Mar 2023
Grant $95.00M 1
Biomedical Advanced Research and Development Authority (BARDA)
01 Mar 2022

FAQ About Stevanato Group

Managing complexity, delivering value.
Stevanato Group was founded in 1949.
Stevanato Group is headquartered in Italy.
Stevanato Group operates in Health Care, Manufacturing and Pharmaceutical.
Stevanato Group has approximately 2414 employees.
Stevanato Group has completed 3 funding rounds, raising a total of $555.00M. The latest funding stage is Post-IPO Equity.

We're actively collecting intelligence on Stevanato Group.

Source: BounceWatch company record for Stevanato Group, https://bouncewatch.com/company/stevanato-group, updated 9 May 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes